Diamyd Medical | Sustainability Performance
This company focuses on developing innovative therapies for diabetes management. Its research emphasizes personalized medicine and targets immune responses to improve treatment outcomes.
1994
Sweden
11 - 50 employees
Pharmaceuticals
$0 - 100K in revenue
Not profitable
Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.
Sustainability Ranking & Industry Benchmark
#7557
Overallⓘ#393
in Swedenⓘ#176
in PharmaceuticalsⓘSustainability Maturity
ⓘSustainability Intent
ⓘOverview
Controversy level
Powered by illuminem
Sustainability employees
ⓘWe follow the strictest rules to ensure compliance with all the relevant data protection laws, including GDPR. Click here for our Privacy Policy.Total sustainability employees
1
ⓘThis value represents the estimated number of employees in a company with sustainability-related roles or job titles, as determined by Illuminem using publicly available data.